Snapshot of the Nations Praising HCQ for COVID-19

Written by CryptoNephilim @cryptonephilim (Twitter) on July 31, 2020. Posted in Current News

Health officials from China, Korea, India, Taiwan, Malaysia, Bahrain, Turkey, Jordan, United Arab Emirates, Qatar, Morocco, Algeria, Nigeria, Senegal, Cuba, Italy, and 65 scientific studies have shown hydroxychloroquine is effective when used early against COVID19.

On February 17th, Chinese health officials said that chloroquine was selected out of “tens of thousands of existing drugs after multiple rounds of screening” as the most effective treatment against COVID19.

On February 13th, Korea posted their official treatment guidelines utilizing hydroxychloroquine as a treatment for COVID19, as reported by the Times of Israel:

“Medical treatments have traditionally been a private decision between patients and doctors, but now it seems politicians are usurping their right to choose. According to Dr Jeffrey Singer, a general surgeon and Cato Institute fellow, this threatens the integrity of the medical profession and indirectly imperils patients, by denying them emergency options when no other alternatives are available.

Moreover, the politicization of treatment options would not help Americans, given the fact countries such as Belgium, France and South Korea have used HCQ to treat Covid-19 with a good degree of success.

South Korea was one of the first countries to be hit by the virus after China, reporting its first case on January 20 and peaking by late February, before suddenly tapering off in early March and “flattening the curve.” It also has a comparatively low mortality rate through a combination of testing, tracing, containment and HCQ.

Last month, the Korea Centers for Disease Control and Prevention, the Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, Korean Society of Pediatric Infectious Diseases and a tuberculosis association recommended the use of Kaletra, an anti-HIV medication, in combination with HCQ, to treat Covid-19.

This was bolstered by a French study that showed HCQ had an antiviral effect against Covid-19 in confirmed cases. Used in conjunction with the azithromycin Z-Pak, most patients cleared the virus in three to six days rather than the 20 days observed in China, drastically narrowing the period during which a patient can spread the virus to others.

As such, Dr Jeff Colyer, chairman of the US National Advisory Commission on Rural Health, and Dr Daniel Hinthorn, director of the Division of Infectious Disease at the University of Kansas Medical Center, in a Wall Street Journal article recommended that the US could adopt this approach and use the treatment cocktail early rather than wait until a patient is on a ventilator in an intensive care unit.

To be clear, these scientists and doctors now recommend HCQ as a treatment, not a preventive measure, for Covid-19. They argue that a positive effect of using HCQ early is the reduction of virus transmission to other people given the shorter number of days the patients remain contagious, thereby flattening the curve sooner.”  [Times of Israel]

Health officials from India’s ICMR have successfully been using Hydroxychloroquine as treatment and a preventative measure. The tablets are given to police officers, hospital workers, and family members of those who test positive.

The health director of Malaysia credits hydroxychloroquine for their low fatality rates saying, “We use it for patients that have been diagnosed positive, asymptomatic, or mild symptoms… We realize by using hydroxychloroquine, we can delay or even stop the progression.”

“Health director-general Dr Noor Hisham Abdullah said the off-label usage of hydroxychloroquine has managed to delay Covid-19 progression among patients in Malaysia, which he noted could have led to low fatality rates in the country.

“The reason we use it is for [Covid-19] patients that have been diagnosed positive, asymptomatic or mild symptoms, and we already have a study on the efficacy and the treatment and we realise that by using the hydroxychloroquine, we can delay or even stop the progression into Category Four and Five. So that is one positive observation that we have done,” he told a press conference, referring to the worst stages of the Covid-19 disease.”  [Kanmani Batumalai  9 June 2020]

Bahrain began using hydroxychloroquine two days after the first case of Covid-19 was discovered there in February. They did this based on “notable success in China and South Korea.” Now they have one of the lowest case fatality rates in the world.

In April, Turkey had the biggest coronavirus outbreak in the Middle East. Turkey’s Ministry of Health says the realtively low death toll is thanks to a treatment protocol including hydroxychloroquine.

“Istanbul — Turkey has the biggest coronavirus outbreak in the Middle East, with more than 117,000 confirmed infections. More than 3,000 people have died. But the government claims to have a lower fatality rate than the global average estimated by the World Health Organization at over 3%.

The Turkish government imposed weekend-only lockdowns and banned only those under the age of 20 and over 65 from leaving their homes during the week, in an effort to limit the economic impact of the pandemic.

Turkey’s Ministry of Health says the relatively low death toll is thanks to treatment protocols in the country, which involve two existing drugs — the controversial anti-malaria drug hydroxychloroquine touted by President Trump, and Japanese antiviral favipiravir.”

In March, Jordan’s FDA authorised physicians to use hydroxychloroquine as a treatment for COVID19 citing international studies.

The Health Minister of the United Arab Emirates credits hydroxychloroquine for reducing the duration of patient’s illness and the severity of their symptoms. The nation has been succesfully treating COVID19 patients with HCQ since April.

The Health Minister of Qatar in an interview with Al Jazeera said that Qatar is using hydroxychloroquine with “great success” and has a relatively low case fatality rate compared to other nations.

Despite safety concerns by the World Health Organization, Morocco’s health minister says “chloroquine leads to faster recovery” and that they intend to continue usage. Morocco credits hydroxychloroquine for their success in treating COVID19.

Health officials in Algeria have claimed to have “great success” using hydroxychloroquine in combination with antibiotics and have “not noted any adverse reactions” among several thousand patients who have been given the treatment.

Nigeria has found success with using hydroxychloroquine as a prophylaxis for COVID19.

In March, Health Officials from Senegal found “no complications and no deaths in patients treated with hydroxychloroquine”. They said they will continue treatment with hydroxychloroquine

Cuban Medical Authorities have found “early hydroxychloroquine potent against COVID19”. Health officials are using low doses of the antimalarial drug to effectively treat patients in the early stages of the disease.

Costa Rica has been using hydroxychloroquine to treat early since a teleconference with health officials from China on March 18th. They now boast one of the lowest fatality rates in the world.

On March 29th, Italy finally began mass treatment with hydroxychloroquine. Italy’s death rate peaked a few days later and has continued to drop since then.

On April 2nd, a global survey of 6,000 doctors from 30 countries found hydroxychloroquine as the “most effective therapy” from a list of 15 options.

In July, a professor of epidemiology at Yale wrote a paper claiming that “the data fully supports hydroxychloroquine” and the anti-malarial drug “is the key to defeating COVID19”. He argued that “tens of thousands of patients are dying unnecessarily without the drug”

In April, The American Physicians and Surgeons (AAPS) wrote a letter saying that peer reviewed studies since January have provided clear and convincing evidence that HCQ may be beneficial in treating COVID19. In observational studies of 2137 patients, 91.6% improved clinically.

There are now 65 hydroxychloroquine studies that show high effectiveness as an early treatment against COVID19, while late treatment shows mixed results.

Hydroxychloroquine has been safely prescribed to hundreds of millions since 1955. The CDC website literally says that it can be “safely taken by pregnant women and children”. The WHO list it as an essential medicine.

How does Africa have a lower death rate than the United States and the rest of the world? Hydroxychloroquine.

Peer-reviewed, retrospective analysis of 2,541 patients found “Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients” “Our analysis shows that using hydroxychloroquine helped saves lives,” said neurosurgeon Dr. Steven Kalkanis, CEO, Henry Ford Medical Group.

“It has been deflating to see how the science has been corrupted..to disparage hydroxychloroquine”, said former UCLA Professor & Harvard MD, Dr. George Fareed. “By far the best tool has been the combination of hydroxychloroquine, with either azithromycin or doxycycline and zinc.”

“BRAWLEY – A front-line local doctor treating COVID-19 patients claims to have figured out what works to keep his patients alive. He claims to have answers on better controlling, and curbing, a pandemic that knows no boundaries.

Dr. George Fareed is a physician who can be spotted during football season as local high school’s field doctor working with athletes from Holtville, El Centro, Imperial, and lately, with Brawley Union High School.

Fareed graduated with honors in 1970 at Harvard and pursued medical studies, research, and teaching at Harvard and UCLA in the first 20 years of his career. Fareed returned to clinical medicine in 1991 when he came to the Imperial Valley to establish a general practice.

He began zoom meetings with other front-line doctors on the east coast and found they had the same experiences he did, finding what worked and what didn’t, finding preventatives before exposures, and keeping his patients alive.

The frustration levels rose between Fareed and other doctors that action had to be taken, he said. Fareed has written letters to President Trump, Representative Juan Vargas, and the Presidential Task Force. He continues Zoom meetings with other doctors, and hope to get to Washington D.C. to share their knowledge and results.

Here is the letter Fareed sent to President Trump:

Dear President Trump and Task Force,

My name is Dr. George Fareed. I am a physician in Imperial County, California, that has been hit hard by the COVID-19 pandemic. I take care of patients on both an outpatient and inpatient basis, as well as nursing home patients, the most vulnerable among us.

In this letter, I am proposing a medical strategy that can help us not only through this current crisis, but also that will enable us to approach outbreaks of COVID-19 that may occur in the future.

In my attempts to keep people alive, I have had an opportunity to use many different types of treatments — remdesivir, dexamethasone, convalescent plasma replacement, etc.

Yet, by far the best tool beyond supportive care with oxygen has been the combination of hydroxychloroquine (HCQ), with either azithromycin or doxycycline, and zinc. This “HCQ cocktail” (that costs less than $100) has enabled me to prevent patients from being admitted to the hospital, as well as help those patients that are hospitalized. The key is giving the HCQ cocktail early, within the first five days of the disease.”

Follow CryptoNephilim @cryptonephilim on Twitter.

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Please DONATE TODAY To Help Our Non-Profit Mission To Defend The Scientific Method.

Trackback from your site.